Pablo Aja-Macaya

8PUBLICATIONS
61CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Microbial geneticsMicrobial ecologyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 19, 2026
In vivo emergence of ceftazidime/avibactam resistance in Pseudomonas aeruginosa driven by OXA-1381, a novel W157L Ω-loop variant of OXA-2.

|Aug 13, 2026
FTIR typing of the emerging NDM-14-producing Klebsiella pneumoniae ST147 clone.

|May 29, 2026
Comparative activity of ceftibuten combinations with avibactam, ledaborbactam, and xeruborbactam against recombinant β-lactamase-producing Escherichia coli and contemporary WGS-characterized strains of carbapenemase-producing Enterobacterales.

|May 29, 2026
Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in Pseudomonas aeruginosa.

|Mar 27, 2026
Emergence of KPC-producing Pseudomonas aeruginosa in Spain: insights into an outbreak and resistance to the novel carbapenem/β-lactamase inhibitor combinations imipenem/relebactam and meropenem/vaborbactam.

Gloria Pérez-Rodríguez, Pablo Aja-Macaya, Lucía González-Pinto

|Jul 25, 2025
Broad spectrum of β-lactamase coverage and potent antimicrobial activity of xeruborbactam in combination with meropenem against carbapenemase-producing Enterobacterales, including strains resistant to new β-lactam/β-lactamase inhibitor combinations.

Lucía Sánchez-Peña, Salud Rodríguez-Pallares, Pablo Aja-Macaya

Pageof 2

Frequent Collaborators

7 joint publications

Germán Bou

6 joint publications

Tania Blanco-Martín

6 joint publications

Jorge Arca-Suárez

5 joint publications

Gloria Pérez-Rodríguez